{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:51:57Z","timestamp":1763135517120,"version":"3.45.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"DOI":"10.1186\/s12871-025-03421-3","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:47:07Z","timestamp":1763135227000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intensive Care management of Hemophagocytic Lymphohistiocytosis: a case series"],"prefix":"10.1186","volume":"25","author":[{"given":"Riccardo","family":"Traversi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Arrigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Bonetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Sales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Busca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vito","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Filippini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Brazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgia","family":"Montrucchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,14]]},"reference":[{"key":"3421_CR1","doi-asserted-by":"publisher","unstructured":"Hines MR, et al. Consensus-based guidelines for the recognition, diagnosis, and management of hemophagocytic lymphohistiocytosis in critically Ill children and adults. Crit Care Med. 2022;50: 860\u2013872 . https:\/\/doi.org\/10.1097\/CCM.0000000000005361.","DOI":"10.1097\/CCM.0000000000005361"},{"key":"3421_CR2","doi-asserted-by":"publisher","unstructured":"Griffin, G., Shenoi, S. & Hughes, G. C. Hemophagocytic lymphohistiocytosis:an update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol.\u00a02020;34:101515. https:\/\/doi.org\/10.1016\/j.berh.2020.101515.","DOI":"10.1016\/j.berh.2020.101515"},{"key":"3421_CR3","doi-asserted-by":"publisher","unstructured":"Sandler RD, et al. Diagnosis and management of secondary HLH\/MAS following HSCT and CAR-T cell therapy in adults; a review of the literature and a survey ofpractice within EBMT centres on behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP). Front Immunol. 2020;11:524. https:\/\/doi.org\/10.3389\/fimmu.2020.00524.","DOI":"10.3389\/fimmu.2020.00524"},{"key":"3421_CR4","doi-asserted-by":"publisher","unstructured":"Fardet L, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66:2613\u20132620. https:\/\/doi.org\/10.1002\/art.38690.","DOI":"10.1002\/art.38690"},{"key":"3421_CR5","doi-asserted-by":"publisher","unstructured":"Henter JI, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124\u2013131. https:\/\/doi.org\/10.1002\/pbc.21039.","DOI":"10.1002\/pbc.21039"},{"key":"3421_CR6","doi-asserted-by":"publisher","unstructured":"Finazzi S, et al. PROSAFE: a European endeavor to improve quality of critical care medicine in seven countries. Minerva Anestesiol. 2020;86:1305\u20131320. https:\/\/doi.org\/10.23736\/S0375-9393.20.14112-9.","DOI":"10.23736\/S0375-9393.20.14112-9"},{"key":"3421_CR7","doi-asserted-by":"publisher","unstructured":"Corcione S, et al. V348I mutation in UL23 gene of human herpesvirus 1 in a case of herpetic hepatitis and haemophagocytic lymphohistiocytosis. New Microbes New Infect. 2019;29:100529. https:\/\/doi.org\/10.1016\/j.nmni.2019.100529.","DOI":"10.1016\/j.nmni.2019.100529"},{"key":"3421_CR8","doi-asserted-by":"publisher","unstructured":"Knaak C, et al. Treatment and mortality of hemophagocytic lymphohistiocytosis in adult critically ill patients: a systematic review with pooled analysis. Crit Care Med. 2020;48:e1137-e1146. https:\/\/doi.org\/10.1097\/CCM.0000000000004581.","DOI":"10.1097\/CCM.0000000000004581"},{"key":"3421_CR9","doi-asserted-by":"publisher","unstructured":"AB, et al. High mortality of hlh in icu regardless etiology or treatment - PubMed. Frontiers in medicine\u00a02021;8. https:\/\/doi.org\/10.3389\/fmed.2021.735796.","DOI":"10.3389\/fmed.2021.735796"},{"key":"3421_CR10","doi-asserted-by":"publisher","unstructured":"Elisabet Bergsten, 2 AnnaCarin Horne,1,2 Maurizio Aric \u00b4 o,3 Itziar Astigarraga,4 R. Maarten Egeler,5 Alexandra H. Filipovich,6, Eiichi Ishii, G. J., 8 Stephan Ladisch,9 Kai Lehmberg,8 Kenneth L. McClain,10 Milen Minkov,11 & Scott Montgomery, -. V. N., 15 Diego Rosso,16\u201319 and Jan-Inge Henter1,2. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood. 2017;130:2728\u20132738. https:\/\/doi.org\/10.1182\/blood-2017-06-788349.","DOI":"10.1182\/blood-2017-06-788349"},{"key":"3421_CR11","doi-asserted-by":"publisher","unstructured":"Philipp Wohlfarth, M., Hermine Agis, MD1,2, Guido A. Gualdoni, MD, PhD3,, Johannes Weber, M., Thomas Staudinger, MD1, & Peter Schellongowski, M., and Oliver Robak, MD1. Interleukin 1 receptor antagonist anakinra, intravenous immunoglobulin, and corticosteroids in the management of critically ill adult patients with hemophagocytic lymphohistiocytosis. Journal Of Intensive Care Medicine. 2019;34:723\u2013731. https:\/\/doi.org\/10.1177\/0885066617711386 .","DOI":"10.1177\/0885066617711386"},{"key":"3421_CR12","doi-asserted-by":"publisher","unstructured":"Laura Scholz M, et al. Ruxolitinib, IV immunoglobulin, and high-dose glucocorticoids for critically ill adults with secondary hemophagocytic lymphohistiocytosis: a single-center observational pilot study. Critical Care explorations. 2024. https:\/\/doi.org\/10.1097\/CCE.0000000000001046 .","DOI":"10.1097\/CCE.0000000000001046"},{"key":"3421_CR13","doi-asserted-by":"publisher","unstructured":"Shanmuganathan Chandrakasan, M. B. J., 2,3 Ashley Baker,4 Edward M. Behrens,5 Deepika Bhatla,6 May Chien,7, Olive S. Eckstein, M. M. H., 9 Michelle L. Hermiston,10 Ashley P. Hinson,11 Jennifer W. Leiding,12 Abiola Oladapo,13, Sachit A. Patel, P. P., 15 Anish K. Ray,16 Blachy D\u00b4 avila Salda\u02dc, na, S. N. S., 18 Kelly J. Walkovich,19 John D. Yee,13 & Adi Zoref-Lorenz, 20 and Carl E. Allen,8 on behalf of the REAL-HLH Investigators. Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab. Blood advances. 2024;8:2248\u20132258. https:\/\/doi.org\/10.1182\/bloodadvances.2023012217 .","DOI":"10.1182\/bloodadvances.2023012217"},{"key":"3421_CR14","doi-asserted-by":"publisher","unstructured":"Shakoory1 B, et al. The 2022 EULAR\/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis\/macrophage activation syndrome (HLH\/MAS). Ann Rheum Dis. 2023;82:1271\u20131285. https:\/\/doi.org\/10.1136\/ard-2023-224123.","DOI":"10.1136\/ard-2023-224123"}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-025-03421-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-025-03421-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-025-03421-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T15:47:07Z","timestamp":1763135227000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-025-03421-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3421"],"URL":"https:\/\/doi.org\/10.1186\/s12871-025-03421-3","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"3 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics Committee \u201cComitato Etico Interaziendale AOU Citt\u00e0 della Salute e della Scienza, AO Mauriziano, ASL Citt\u00e0 di Torino\u201d waived the need for patients\u2019 consent due to the retrospective observational nature of this study. This study was conducted in accordance with the ethical standards of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate\u00a0"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"562"}}